Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QRX-203
- Development stage
- Preclinical
- Lead developer
- ProQR Therapeutics
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
QRX-203 is an RNA-based therapeutic developed for the treatment of Alzheimer's disease. It is part of ProQR’s research pipeline, which focuses on single-stranded RNA (ssRNA) antisense molecules that are chemically modified to enable targeted repair of genetic mutations. These oligonucleotide therapies are intended to restore or modify protein function, although the precise molecular target and mechanism for QRX-203 in Alzheimer's disease have not been publicly disclosed. All ProQR antisense molecules, including QRX-203, are designed to be vector-free and are manufactured via relatively simple, scalable processes[1][4].
02
Targets
Amyloid precursor protein mRNA
Beyond the preview
Go deeper on QRX-203.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QRX-203.